Healthcare company Glovax joins Business Call to Action by expanding access to vaccinations in the Philippines
QUEZON CITY, Philippines, March 30, 2017 /3BL Media/ – Glovax Biotech Corp., an integrated distributor and retailer of vaccines in the Philippines, has joined Business Call to Action (BCtA) with a commitment to provide 40 million vaccine doses to the country’s medium- and low-income communities by 2020, reducing the cost of vaccinations by 75 percent and preventing countless disease outbreaks.
It can take longer to diagnose rare diseases than many common diseases. On average, rare disease diagnosis takes 7.6 years in the U.S. and 5.6 years in the UK. Rare diseases such as the primary immunodeficiency (PI) disorders Gaucher disease, Fabry disease, and Hunter syndrome can be devastating, as they are difficult to detect and equally difficult to treat. 60,000 Our U.S. patient assistance programs reached approximately 60,000 patients. We have 37 programs in clinical development, the most robust pipeline in Shire’s history.
After more than six decades of fighting the spread of trachoma in Morocco, on November 14, 2016, the World Health Organization (WHO) acknowledged that the Moroccan government eliminated the world’s leading infectious cause of blindness as a public health problem.